ELIZABETH LIVINGSTON: Open Payments
NPI 1386878361 · MUSCLE SHOALS, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 32 payments from 15 companies in 2025. Trend: 2023 $619 · 2024 $468 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $171 |
| Novo Nordisk Inc | 5 | $88 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $46 |
| Ardelyx, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $31 |
| Amgen Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
Products named: AIRSUPRA, BREZTRI, Wegovy, FARXIGA, FANAPT, IBSRELA, Ozempic, ZEPBOUND.
Industry payments across AL — which companies pay providers there.
